Eminence Business Media - A Eminence Group Company’s Post

Explore the Life Sciences Landscape in the West of Ireland! Ever wondered what life sciences companies have operations in the west of Ireland? From pharmaceutical giants to innovative biopharma and medical device firms, the west of Ireland is buzzing with activity. Below are just some of the remarkable players shaping the future of healthcare in this region. Galway has successfully grown to become the #1 location for medical technology in Ireland. Looking beyond Galway, Sligo and Mayo have a strong mix of biopharma and medical technology with ongoing investments and growth. Limerick is beginning to build a biopharma research and manufacturing hub, while the Athlone biopharma cluster has recently had exciting news with the purchase of Alkermes by NovoNordisk. At LSC, we are at the heart of projects across the country. For your sourcing needs, market analysis and insights, or more info on our project solutions, please don't hesitate to reach out! #LifeSciences #Innovation #WestOfIreland

Building a shared vision for pharma R&D–supplier partnerships: Pharma R&D leaders and their suppliers see transparency as a key to unlocking more effective collaborations and cost efficiencies. http://dlvr.it/THK3Vs

🌐 Join the MPP Association and lead the future of health innovation 🌐 The Medtech & Pharma Platform Association brings together key companies across the pharmaceutical, medtech, and diagnostic sectors that are actively working on developing and improving access to combined products. Here’s how MPP membership empowers you to make an impact: 🔹 Policy dialogue: Contribute to working groups and engage with regulators to proactively shape future healthcare policy & regulation 🔹 Insights: Stay ahead with updates on policy changes impacting combined products 🔹 Networking: Connect with key stakeholders to drive innovative healthcare solutions 🔹 Access to expertise: Benefit from a network and a robust knowledge pool for combined products 🔹 Membership benefits: Enjoy reduced rates at the MPP Annual Conference and access to other events 📈 Join us to shape tomorrow's health solutions: https://bit.ly/3KGx1hz #CombinedProducts #Pharma #Medtech #IVDs

Amid tightening budgets, 50% of the top 20 leading pharma firms are prioritizing technology to achieve efficiency gains, as pressures on clinical services spending continue to grow. Uncover strategies for life sciences service providers to drive performance in a challenging market environment. https://atbain.co/3V0Ve7X

In my journey, CME, RTM, DMP these tools have been instrumental in fostering strong relationships and educating both doctors and myself about groundbreaking pharmaceutical products. Through these sessions, I've had the privilege to engage in meaningful discussions, enhancing our collective knowledge and understanding . The ability to connect with doctors in real-time has been transformative. From sharing vital updates to addressing queries promptly, it's all about staying agile and responsive in an ever-evolving landscape. And let's not forget that it also gives the chance to personally connect with healthcare professionals, build trust, and deepen our collaboration. I've had the honour of facilitating enriching experiences. These moments exemplify the strong bonds forged and the commitment to advancing healthcare together. Looking forward to continued success in leveraging these powerful tools! 💼📚 #PharmaSales #RelationshipBuilding #ProductEducation #Innovation #PharmaEducation #RelationshipBuilding #Collaboration #StrongerTogether #PharmaRelationships #HealthcareEmpowerment #CollaborativeEfforts #ContinuousLearning #HealthcareTransformation #BridgeBuilders #TrustBuilding #PharmaSuccess #StrongerBonds #Agility #LinkedInPost

It’s really good to see performance of some pharma companies , They have 𝐬𝐞𝐭𝐬 𝐭𝐡𝐞 𝐛𝐚𝐫 𝐚𝐠𝐚𝐢𝐧: 𝐇𝐢𝐠𝐡𝐞𝐬𝐭 𝟓-𝐘𝐞𝐚𝐫𝐬 𝐂𝐀𝐆𝐑 𝐚𝐦𝐨𝐧𝐠 𝐓𝐨𝐩 𝟏𝟎𝟎 𝐏𝐡𝐚𝐫𝐦𝐚 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧𝐬 In the realm of pharma corporate growth, few companies has emerged again with boasting the highest 𝐂𝐀𝐆𝐑 (Compound Annual Growth Rate) among the top 100 Pharma Corporates for the past 5 years, as per PharmaTrac Data …

A wave of private equity activity in 2020–2021 has set the stage for significant M&A activity in the outsourced pharma services and pharma tech space, with 20+ notable platforms expected to come to market in 2024–2025. In addition, increased complexity of regulatory requirements and pressure on pharma companies to outsource more to specialized vendors are driving greater opportunities for investors in the sector. Our Q2 brief shares observations and key themes impacting the market, including the rising complexity and cost of the R&D process, supply chain visibility, legacy commercialization approaches, tech implementation, challenges with payers, and drivers for pharma services activity in 2024. https://lnkd.in/e2Zr_X8J

A wave of private equity activity in 2020–2021 has set the stage for significant M&A activity in the outsourced pharma services and pharma tech space, with 20+ notable platforms expected to come to market in 2024–2025. In addition, increased complexity of regulatory requirements and pressure on pharma companies to outsource more to specialized vendors are driving greater opportunities for investors in the sector. Our Q2 brief shares observations and key themes impacting the market, including the rising complexity and cost of the R&D process, supply chain visibility, legacy commercialization approaches, tech implementation, challenges with payers, and drivers for pharma services activity in 2024. https://lnkd.in/e9jJ9rR6

As companies move closer to launch, the use of RWD and Payer Insights play an important role in helping market access teams establish a commercially focused approach to drive launch excellence. Short read that highlights steps your team can take as you plan for your product's launch. Let me know if there is interest in learning more.

Pharma companies have many market access tasks to complete in the year leading up to launch. MMIT’s Ryan Witherington and Carolyn Zele share six key areas to focus on: https://ow.ly/sXkh50TyVth